How does EquitAI evaluate Corteva, Inc.'s (CTVA) valuation and Stock DNA?

Corteva, Inc. (CTVA) trades at $11.64 with an EquitAI Valuation DNA score of 2/10 and Quality score of 9/10. The company's trailing P/E ratio is 51.3x. These scores evaluate balance sheet leverage, free cash flow generation, and fundamental multiples against historical benchmarks.

What sector and industry does Corteva, Inc. (CTVA) operate in?

Corteva, Inc. (CTVA) is classified under the Basic Materials sector within the Agricultural Inputs industry. EquitAI benchmarks its fundamental valuation and financial DNA metrics against both direct Agricultural Inputs peers and broader Basic Materials market benchmarks.

What is Wall Street's price target and consensus rating for Corteva, Inc. (CTVA)?

Wall Street analysts have a consensus 12-month price target of $38.6 for Corteva, Inc. (CTVA), representing an implied 232.0% upside from its current trading level of $11.64 with an average rating of Buy based on 14 analyst ratings. Individual analyst price targets range from a low of $15.0 to a high of $101.0, with a median forecast of $17.0. EquitAI benchmarks analyst consensus projections against intrinsic Financial DNA valuation pillars.

Does CTVA pay dividends or capital distributions?

Corteva, Inc. has an indicated annual dividend yield of 1.36%. Dividend stability is factored into its Income DNA pillar alongside free cash flow coverage.

Who are Corteva, Inc.'s (CTVA) primary market competitors and peers?

Key market peers and semantic competitors include FMC, BIOX, NTR, CF. EquitAI maps peer relationships through semantic business models, institutional capital flow correlation, and market capitalization weighting.

How should investors interpret EquitAI's CTVA analysis?

EquitAI provides quantitative financial research, algorithmic DNA scores, and SEC contextual analytics for informational and research purposes. It does not constitute personalized financial advice or broker-dealer investment recommendations.

CTVA - Corteva, Inc. Stock Analysis & Valuation

$11.64

+1.48%

Corteva, Inc.

•Basic Materials

Agriscience

Crop Protection

Wide Moat

Institutional Favorite

Agriscience

Crop Protection

Wide Moat

Institutional Favorite

Loading Chart...

FIT ANALYSIS

Required for personalization

FIT ANALYSIS

Checking Membership...

STOCK DNA

Valuation

2/10

Quality

9/10

Growth

6/10

Strength

7/10

Dividend

3/10

Similar Stocks

FMC FMC Corporation

BIOX Bioceres Crop Solutions Corp.

NTR Nutrien Ltd.

CF CF Industries Holdings, Inc.

AVD American Vanguard Corporation

Health Indicators

Price Trend

Upwards

Momentum

Neutral

Balance Sheet

Healthy

Earnings

Growth

Dividend Yield

1.36%

Market Cap

$7.77B

TALK TO YOUR STOCK

EQUITAI ASSISTANT

Corteva is a global agricultural chemical and seed company that develops innovative products to help farmers increase crop yields. The company focuses on advanced seed genetics and specialized crop protection solutions to support the global food supply chain. I have synthesized my analysis of its core fundamentals, live market action, and peer metrics to provide a comprehensive thesis. What specific areas can I detail for you?

AI can make mistakes. Verify important information.

Talk to Your Stock•open live chat

Pro EquitAI Research Report

“A high-quality agriscience titan backed by massive institutional support.”

Wall St. Consensus

232.0% Upside

$38.6

(Based on 14 ratings)

Bullish

EquitAI Sentiment

BULLISH

Unlock AI Sentiment

Reveal whether our AI rates this asset as Bullish, Bearish, or Neutral.

Generated on October 23, 2026

Reference Price: $12.86

Corteva is currently navigating a choppy agricultural cycle, balancing slightly contracted earnings against its undisputed market dominance. With deep roots in the global food supply chain, the company is leaning on its massive institutional backing and high-margin product mix to weather near-term macroeconomic headwinds.

The Bull Case

Corteva wields exceptional pricing power in its seed and crop protection portfolios, which helps it maintain an impressive 17% operating margin that vastly outpaces industry peers.
The business generates massive cash flow effortlessly, boasting a robust 7.3% free cash flow yield that provides plenty of firepower for research, development, and shareholder returns.

The Bear Case

The stock currently commands a steep premium, trading at a trailing price-to-earnings ratio of 56.7, which leaves little room for error if macroeconomic conditions worsen.
Earnings growth has recently slipped by 11.6%, reflecting the highly cyclical nature of farmer incomes and broader global commodity fluctuations.

Business Engine & Moat
Economic Moat: A company's distinct competitive advantage that protects its market share and profitability from competitors.
Wide

Corteva stands as a pure-play agriscience titan following its spin-off from DowDuPont. Its competitive advantage is built on a massive, patent-protected library of seed genetics and specialized crop protection chemicals. Because switching suppliers can jeopardize a farmer's entire harvest, customer retention is incredibly sticky and pricing power remains robust.

Financial DNA & Smart Money

Deep institutional capital flow signals, smart money positioning, structural balance sheet resilience, and comprehensive multi-factor fundamental decomposition.

The Premium Verdict

Final institutional rating rationale, strategic time-horizon recommendation, target price probabilities, and core investment verdict.

Unlock the Full AI Analysis

Create a free account to instantly reveal the AI Sentiment, Financial DNA deep dive, and the final Premium Verdict.

This report is based on up-to-date financial fundamentals and Wall Street projections.

Recent SEC Filings & Insights

8-K

Oct 13, 2026

BEARISH

Corteva faces litigation challenging its recent separation, which led to a temporary restraining order (now stayed) prohibiting asset disposals, dividends, and share repurchases. The company has voluntarily committed to not paying dividends or repurchasing shares pending appeal.

8-K

Oct 7, 2026

NEUTRAL

Corteva, Inc. completed the previously announced separation of its seed operating segment into Vylor Inc., an independent publicly traded company. This structural reorganization led to significant changes in Corteva's board of directors and executive leadership.

8-K

Oct 7, 2026

NEUTRAL

Corteva's subsidiary, EIDP, Inc., completed a private exchange offer where a substantial portion of its outstanding senior notes were exchanged for new Vylor Inc. notes, leading to the retirement and cancellation of the EIDP notes and amendments to their governing indentures.

8-K

Oct 5, 2026

NEUTRAL

Corteva, Inc. has completed the spin-off of its seed operating segment, creating a new independent public company, Vylor Inc., through a pro rata distribution of Vylor shares to Corteva stockholders. This separation was effective October 1, 2026, fundamentally altering Corteva's corporate structure.

8-K

Oct 1, 2026

NEUTRAL

Corteva, Inc. is proceeding with its previously announced separation into two independent, publicly traded companies, Corteva and Vylor Inc., after a legal challenge from California was denied. The distribution of Vylor shares is expected to be completed on October 1, 2026.

Quick Facts & Methodology FAQ

CTVA Overview

Have more questions about CTVA? Ask our AI financial analyst.

CTVA - Corteva, Inc. Stock Analysis & Valuation

Corteva, Inc.

FIT ANALYSIS

Pro EquitAI Research Report

The Bull Case

The Bear Case

Business Engine & MoatEconomic Moat: A company's distinct competitive advantage that protects its market share and profitability from competitors. Wide

Financial DNA & Smart Money

The Premium Verdict

Unlock the Full AI Analysis

Recent SEC Filings & Insights

Business Engine & Moat
Economic Moat: A company's distinct competitive advantage that protects its market share and profitability from competitors.
Wide